EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 94 filers reported holding EDGEWISE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,902,478 | -26.1% | 1,553,661 | 0.0% | 11.43% | +10.6% |
| Q2 2023 | $12,040,873 | +16.2% | 1,553,661 | 0.0% | 10.34% | +20.8% |
| Q1 2023 | $10,362,919 | -25.4% | 1,553,661 | 0.0% | 8.56% | -14.8% |
| Q4 2022 | $13,889,729 | -9.1% | 1,553,661 | 0.0% | 10.06% | +10.8% |
| Q3 2022 | $15,288,000 | +23.6% | 1,553,661 | 0.0% | 9.07% | +13.2% |
| Q2 2022 | $12,367,000 | -17.9% | 1,553,661 | 0.0% | 8.01% | +7.9% |
| Q1 2022 | $15,071,000 | -36.5% | 1,553,661 | 0.0% | 7.43% | -13.6% |
| Q4 2021 | $23,740,000 | -8.0% | 1,553,661 | 0.0% | 8.60% | +15.6% |
| Q3 2021 | $25,791,000 | -41.1% | 1,553,661 | 0.0% | 7.44% | -33.8% |
| Q2 2021 | $43,783,000 | -13.3% | 1,553,661 | 0.0% | 11.24% | -4.4% |
| Q1 2021 | $50,494,000 | – | 1,553,661 | – | 11.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $8,902,478 | 11.43% |
| Novo Holdings A/S | 6,071,703 | $34,790,858 | 2.57% |
| Orbimed Advisors | 14,567,176 | $83,469,918 | 1.77% |
| Opaleye Management Inc. | 875,405 | $5,016,071 | 1.63% |
| Cormorant Asset Management, LP | 2,946,887 | $16,885,663 | 0.98% |
| DAFNA Capital Management LLC | 519,384 | $2,976,070 | 0.93% |
| EcoR1 Capital, LLC | 3,493,194 | $20,016,002 | 0.68% |
| Deep Track Capital, LP | 2,750,000 | $15,757,500 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $22,536,875 | 0.50% |
| Parkman Healthcare Partners LLC | 473,312 | $2,712,078 | 0.50% |